Syntex Corp.: The Palo Alto pharmaceutical company...
- Share via
From Times Staff and Wire Service Reports
Syntex Corp.: The Palo Alto pharmaceutical company said second-quarter net income totaled $72 million, down 14% from the same period a year ago. Sales rose 4% to $342.7 million. The company said the decline in earnings was primarily due to significant investments in marketing, higher research expenses and a lower tax rate in the year-ago period.
Tables, D13
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
